Identification of an immune‐related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma-Reference-Cited by-同舟云学术

Identification of an immune‐related gene signature as a prognostic target and the immune microenvironment for adrenocortical carcinoma

Published:2022-08-17 Issue:9 Volume:10 Page:
ISSN:2050-4527
Container-title:Immunity, Inflammation and Disease
language:en
Short-container-title:Immunity Inflam & Disease

Author:

Xu Chengdang¹^ORCID,Qin Caipeng²,Jian Jingang³,Peng Yun²,Wang Xinan¹,Chen Xi¹,Wu Denglong¹,Song Yuxuan²⁴

Affiliation:

1. Department of Urology, Tongji Hospital, School of Medicine Tongji University Shanghai China

2. Department of Urology Peking University People's Hospital Beijing China

3. Department of Urology, The First Affiliated Hospital of Soochow University, Dushu Lake Hospital Affiliated to Soochow University Suzhou Medical College of Soochow University Suzhou China

4. Department of Urology Tianjin Medical University General Hospital Tianjin China

Funder

Science and Technology Commission of Shanghai Municipality

Shanghai Hospital Development Center

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/iid3.680

Reference49 articles.

1. Adrenocortical Carcinoma

2. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

3. Adrenocortical carcinoma: a clinician's update

4. Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options

5. Role of reoperation in recurrence of adrenal cortical carcinoma: Results from 188 cases collected in the Italian National Registry for Adrenal Cortical Carcinoma